Course 2 of 5

Optimize Your Bloodwork

Move beyond "normal" lab ranges. Six lessons covering which biomarkers matter for longevity, what guideline categories mean, how to order the right tests, and how to interpret results with evidence-based context.

📖 6 lessons⏱ ~40 minutes📊 Intermediate🔓 100% free
Lesson 1 of 6

Reference Ranges, Cut-offs and "Optimal" Claims

The Problem with "Normal"

When your doctor says your labs are "normal", it means your values fall within the lab's reference range, usually the middle 95% of results in people the lab considers healthy. A normal result is reassuring but not a guarantee, and for some markers, such as LDL cholesterol, risk keeps falling as the number improves.

Guidelines handle this with cut-offs where risk changes. For fasting glucose, under 100 mg/dL is normal, 100–125 mg/dL is the prediabetes range and 126 mg/dL or higher is the diabetes range; HbA1c has its own categories (5.7% and 6.5%).[1]

What About "Optimal" Ranges?

Many longevity sources publish tighter "optimal" ranges, such as fasting glucose of 70–85 mg/dL or vitamin D of 40–60 ng/mL. For most markers, no guideline defines such a range, and some are contradicted by evidence: the NIH notes that vitamin D above 50 ng/mL can be associated with adverse effects.[2]

Key Concept

Know which kind of number you are looking at. A reference range describes typical results; a guideline cut-off marks where risk or treatment changes; an "optimal" range is often one source's opinion. This course uses the first two and tells you when a marker has no agreed cut-off.

The Early Detection Window

Some problems show up in blood tests before they cause symptoms. In the Whitehall II study, insulin sensitivity fell steeply in the five years before a type 2 diabetes diagnosis, while fasting glucose rose steeply only in the last three.[3] For heart disease, risk grows with both the level of LDL particles and how long they have been raised.[4]

Knowledge Check
What does a lab reference range describe?
The values linked to the lowest disease risk
The middle 95% of results in people the lab considers healthy
Targets every adult should aim for
The level at which treatment must start
Correct. A reference range describes typical results in people the lab considers healthy. Guideline cut-offs, such as HbA1c of 5.7% and 6.5%, mark where risk or diagnosis changes, and they are a separate thing.[5]
Lesson 2 of 6

The Longevity Blood Panel

Building the Complete Panel

This course groups tests into two tiers. Tier 1 covers common measures of metabolic and cardiovascular risk; Tier 2 adds tests that matter for some people. The Blood Panel Builder sorts tests by how strongly guidelines support them.

Tier 1: Essential (Get These First)

MarkerWhat it tells youHow it's read
Fasting insulinInsulin resistanceNo agreed cut-off; track it over time alongside glucose
HbA1cThree-month average blood sugarNormal under 5.7% · prediabetes 5.7–6.4% · diabetes 6.5%+[5]
ApoBNumber of atherogenic particlesNo single cut-off; read it with your overall cardiovascular risk[6]
hsCRPInflammation; refines cardiovascular riskLow risk under 1 mg/L · average 1–3 · high over 3[7]
Fasting glucoseCurrent blood sugarNormal under 100 mg/dL · prediabetes 100–125 · diabetes 126+[1]

Tier 2: Important (Add When Possible)

MarkerWhat it tells youHow it's read
HomocysteineCan signal low vitamin B12 or folateRead against your lab's reference range; routine testing to screen for heart disease isn't recommended for everyone[8]
Vitamin D (25-OH)Vitamin D status for bone healthAdequate 20–50 ng/mL · deficiency risk under 12 · above 50 can be associated with adverse effects[2]
DHEA-SAdrenal hormone that declines with ageAge- and sex-specific ranges; in a two-year trial, DHEA supplements did not improve body composition, physical performance or insulin sensitivity[9]
Lp(a)Inherited cardiovascular risk (test once)Under 30 mg/dL (75 nmol/L) rules out risk · over 50 mg/dL (125 nmol/L) rules it in[10]
TriglyceridesMetabolic healthNormal under 150 mg/dL · borderline 150–199 · high 200+[11]
Cost Note

Costs vary widely by lab, insurer and region, so this course gives no prices. Many of these tests are covered when a clinician orders them for a reason; check with your insurer before ordering.

🩸
Blood Panel Builder
Build a list of blood tests to discuss, based on your age, sex and health concerns
→
Knowledge Check
Which marker counts atherogenic particles, because each one carries a single molecule of it?
Total cholesterol
LDL cholesterol
ApoB (apolipoprotein B)
Triglycerides
Correct. Each LDL, VLDL and Lp(a) particle carries one apolipoprotein B molecule, and a 2019 review concluded that ApoB measures the risk from these particles more accurately than LDL cholesterol or non-HDL cholesterol.[6]
Lesson 3 of 6

Metabolic & Cardiovascular Markers

Metabolic Health: The Foundation

Good metabolic health is uncommon: in 2017–2018, only 6.8% of US adults had optimal levels of adiposity, blood glucose, blood lipids and blood pressure with no clinical cardiovascular disease.[12]

Fasting insulin can flag insulin resistance before glucose rises. In the Whitehall II study, insulin sensitivity fell steeply in the five years before a type 2 diabetes diagnosis, while fasting glucose rose steeply only in the last three.[3] There is no agreed cut-off for fasting insulin, so it is best tracked over time alongside glucose.

HOMA-IR (Homeostatic Model Assessment of Insulin Resistance) combines fasting glucose and insulin: glucose (mg/dL) × insulin (µIU/mL) ÷ 405. Studies use different cut-offs to define insulin resistance, and no guideline sets an "optimal" value.

Cardiovascular Risk: Beyond Cholesterol

ApoB: each atherogenic particle (LDL, VLDL, IDL and Lp(a)) carries one ApoB molecule, so ApoB counts the particles that can drive atherosclerosis, while LDL cholesterol measures the cholesterol they carry. A 2019 review concluded that ApoB reflects the risk from these particles more accurately than LDL cholesterol.[6]

Lp(a) is more than 90% determined by genes, and a European consensus panel recommends measuring it at least once in adulthood. The panel treats levels under 30 mg/dL (75 nmol/L) as ruling out Lp(a)-related risk and levels over 50 mg/dL (125 nmol/L) as ruling it in.[10]

Key Concept

Cumulative exposure matters. Across genetic studies, cohorts and trials, the risk of atherosclerotic cardiovascular disease rose with the amount of LDL exposure and appeared to increase with its duration, so lowering it earlier means a longer period of lower exposure.[4]

Knowledge Check
Why is fasting insulin a better early indicator of metabolic problems than fasting glucose?
Insulin resistance can develop years before fasting glucose rises
Glucose testing is less accurate than insulin testing
Insulin is more affected by dietary choices, making it more informative
Fasting glucose doesn't change with metabolic health
Correct. In the Whitehall II study, insulin sensitivity fell steeply in the five years before a type 2 diabetes diagnosis, while fasting glucose rose steeply only in the last three years.[3]
Lesson 4 of 6

Inflammation, Hormones & Nutrients

Inflammation markers

hsCRP (high-sensitivity C-reactive protein) is used to refine cardiovascular risk. A CDC and American Heart Association statement classes levels under 1 mg/L as low risk, 1 to 3 as average and above 3 as high, and treats values above 10 mg/L as a sign of an acute process that calls for retesting.[7]

Homocysteine rises when folate or vitamin B12 runs low. Routine testing to screen for heart disease is not recommended for everyone,[8] and in observational studies a 25% lower homocysteine went with only modestly lower heart disease and stroke risk.[13] Our homocysteine article covers what lowering it has and has not achieved.

Hormonal Health

DHEA-S declines with age and is read against age- and sex-specific ranges. In a two-year randomized trial in older adults with low levels, DHEA supplements had no physiologically relevant benefit on body composition, physical performance, insulin sensitivity or quality of life.[9]

Thyroid tests (TSH, free T4) are worth doing when symptoms or risk factors point to a problem. The US Preventive Services Task Force found the evidence insufficient to recommend screening adults who have no symptoms.[14]

Nutrient Status

Vitamin D: a blood level of at least 20 ng/mL meets the needs of at least 97.5% of people, higher levels were not consistently linked to greater benefit, and some outcomes showed risk at both low and high levels.[15] The NIH notes possible adverse effects above 50 ng/mL,[2] and US guidance finds insufficient evidence to screen adults without symptoms.[16]

Magnesium: status is hard to judge from a blood test because of the way the body handles magnesium across its compartments.[17]

📊
Biomarker Reference Guide
What key markers measure and how to read them
→
Knowledge Check
According to the 2011 Institute of Medicine report, what vitamin D blood level meets the needs of at least 97.5% of people?
10 ng/mL
80 ng/mL
20 ng/mL
100 ng/mL
Correct. The Institute of Medicine concluded that a 25-hydroxyvitamin D level of at least 20 ng/mL meets the requirements of at least 97.5% of the population, and that higher values were not consistently associated with greater benefit.[15]
Lesson 5 of 6

How to Order Tests

Through Your Doctor

The ideal path is requesting these tests through your primary care physician. Many doctors will order expanded panels when you explain your interest in proactive health optimization. Prepare a list of the specific markers you want (use IQH's Blood Panel Builder to generate one) and bring it to your appointment.

Insurance coverage varies by plan and by the reason a test is ordered, so ask what is covered before you order.

Direct-to-Consumer Options

If your doctor won't order certain tests, or you want to skip the appointment, direct-to-consumer labs offer walk-in blood draws:

  • Quest Diagnostics and Labcorp — order online through their consumer portals, walk into any location
  • Ulta Lab Tests, Walk-In Lab, HealthLabs.com — third-party ordering services that use Quest/Labcorp draws

Testing Frequency

There is no evidence-based schedule for repeating a broad longevity panel. Retest a marker when a result, a symptom or a change in treatment calls for it, and ask your clinician how soon. Most people need Lp(a) measured only once in adulthood.[10]

Key Concept

Fasting is not always needed. A European consensus found that non-fasting lipid profiles work for most people: after normal meals, triglycerides rose by at most about 26 mg/dL on average, ApoB, HDL cholesterol and Lp(a) were unaffected, and non-fasting values predicted cardiovascular disease as well as fasting ones.[18] Fasting still matters for fasting glucose and insulin.

🧪
"What Should I Test?" Guide
Interactive decision tool for choosing the right tests based on your situation
→
Knowledge Check
Which marker only needs to be tested once because it's genetically determined?
hsCRP
ApoB
Lp(a)
DHEA-S
Correct. Lp(a) is more than 90% determined by genes, and a European consensus panel recommends measuring it at least once in adults, so one measurement usually establishes it.[10]
Lesson 6 of 6

Interpreting Your Results

Patterns Matter More Than Individual Markers

No single biomarker tells the whole story. Metabolic syndrome is one recognised pattern: any three of raised blood pressure, raised triglycerides, low HDL cholesterol, raised fasting glucose and a large waist.[19] Other patterns sold as "methylation" or "hormonal aging" profiles have no agreed definition.

The Traffic Light Framework

When reviewing results, place each marker in one of three zones based on its guideline or reference category:

  • Green: in the normal or desirable category. No action needed beyond your usual habits.
  • Amber: borderline or mildly outside the usual range. Often worth retesting and raising at your next appointment.
  • Red: clearly outside the usual range. Discuss it with your clinician.

Common Misinterpretations

A few patterns that frequently confuse people:

  • LDL cholesterol is high but ApoB is not: fewer particles are carrying the cholesterol. Because risk tracks the number of particles, ApoB is the better guide when the two disagree.[6]
  • A single high hsCRP result: a value above 10 mg/L suggests a passing infection or injury rather than baseline risk, so a repeat test is usual.[7]
  • Testosterone is "low" but you have no symptoms: the Endocrine Society recommends diagnosing low testosterone only when symptoms and signs are present and morning levels are unequivocally and consistently low on repeat testing.[20]
  • Vitamin D is "high" at 60 ng/mL: that is above the 20–50 ng/mL range the NIH considers adequate, and the NIH notes possible adverse effects above 50, so the flag is worth taking seriously.[2]
Important

IQ Healthspan's tools provide evidence-based interpretation, but they are not a substitute for medical advice. If you identify markers in the "red" zone, discuss them with a qualified healthcare provider.

🔬
Lab Results Interpreter
Enter your bloodwork to see guideline-based interpretations, with sources
→
Knowledge Check
You see elevated LDL-C but normal ApoB. What does this pattern typically indicate?
You have high cardiovascular risk despite the normal ApoB
You likely have large, buoyant LDL particles — lower risk than the LDL-C number suggests
The LDL-C test was probably inaccurate and should be repeated
This pattern is impossible; they always move together
Correct. When LDL cholesterol and ApoB disagree, risk follows the number of particles, which ApoB counts.[6]

References

  1. 1National Institute of Diabetes and Digestive and Kidney Diseases. "Diabetes Tests & Diagnosis." Accessed October 1, 2026. Source
  2. 2NIH Office of Dietary Supplements. "Vitamin D: Fact Sheet for Health Professionals." Accessed October 1, 2026. Source
  3. 3Tabák AG, et al. "Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study." Lancet. 2009;373(9682):2215-21. PubMed · DOI
  4. 4Ference BA, et al. "Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel." Eur Heart J. 2017;38(32):2459-2472. PubMed · DOI
  5. 5MedlinePlus (US National Library of Medicine). "Hemoglobin A1C (HbA1c) Test." Accessed October 1, 2026. Source
  6. 6Sniderman AD, et al. "Apolipoprotein B Particles and Cardiovascular Disease: A Narrative Review." JAMA Cardiol. 2019;4(12):1287-1295. PubMed · DOI
  7. 7Pearson TA, et al. "Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association." Circulation. 2003;107(3):499-511. PubMed · DOI
  8. 8MedlinePlus (US National Library of Medicine). "Homocysteine Test." Accessed October 1, 2026. Source
  9. 9Nair KS, et al. "DHEA in elderly women and DHEA or testosterone in elderly men." N Engl J Med. 2006;355(16):1647-59. PubMed · DOI
  10. 10Kronenberg F, et al. "Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement." Eur Heart J. 2022;43(39):3925-3946. PubMed · DOI
  11. 11MedlinePlus (US National Library of Medicine). "Triglycerides Test." Accessed October 1, 2026. Source
  12. 12O'Hearn M, et al. "Trends and Disparities in Cardiometabolic Health Among U.S. Adults, 1999-2018." J Am Coll Cardiol. 2022;80(2):138-151. PubMed · DOI
  13. 13Homocysteine Studies Collaboration. "Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis." JAMA. 2002;288(16):2015-22. PubMed · DOI
  14. 14LeFevre ML. "Screening for thyroid dysfunction: U.S. Preventive Services Task Force recommendation statement." Ann Intern Med. 2015;162(9):641-50. PubMed · DOI
  15. 15Ross AC, et al. "The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know." J Clin Endocrinol Metab. 2011;96(1):53-8. PubMed · DOI
  16. 16Krist AH, et al. "Screening for Vitamin D Deficiency in Adults: US Preventive Services Task Force Recommendation Statement." JAMA. 2021;325(14):1436-1442. PubMed · DOI
  17. 17Workinger JL, et al. "Challenges in the Diagnosis of Magnesium Status." Nutrients. 2018;10(9). PubMed · DOI
  18. 18Nordestgaard BG, et al. "Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine." Eur Heart J. 2016;37(25):1944-58. PubMed · DOI
  19. 19Alberti KG, et al. "Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity." Circulation. 2009;120(16):1640-5. PubMed · DOI
  20. 20Bhasin S, et al. "Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline." J Clin Endocrinol Metab. 2018;103(5):1715-1744. PubMed · DOI